Hypoxic preconditioning protects rat hearts against ischaemia–reperfusion injury: role of erythropoietin on progenitor cell mobilization

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Physiology

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1113/jphysiol.2008.160887PMID 18845609PMCID PMC2655408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transient receptor potential vanilloid type 1 channels act as mechanoreceptors and cause substance P release and sensory activation in rat kidneys.

  2008influential reference
• Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction

  2008cited by this paper
• Role of oxidative stress in PKC-δ upregulation and cardioprotection induced by chronic intermittent hypoxia

  2007cited by this paper
• Chronic intermittent hypoxia alters Ca2+ handling in rat cardiomyocytes by augmented Na+/Ca2+ exchange and ryanodine receptor activities in ischemia-reperfusion.

  2007cited by this paper
• Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.

  2007influential reference
• Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

  2007cited by this paper
• Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia.

  2007cited by this paper
• Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice.

  2007cited by this paper
• Organ protection by hypoxia and hypoxia-inducible factors.

  2007cited by this paper
• Structural Localization and Expression of CXCL12 and CXCR4 in Rat Heart and Isolated Cardiac Myocytes

  2007cited by this paper
• VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.

  2006cited by this paper
• Intermittent high altitude hypoxia inhibits opening of mitochondrial permeability transition pores against reperfusion injury.

  2006cited by this paper
• Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy.

  2006cited by this paper
• CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

  2006cited by this paper
• Cardiac genomic response following preconditioning stimulus.

  2006cited by this paper
• Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

  2006cited by this paper
• Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells

  2005cited by this paper
• New avenues of exploration for erythropoietin.

  2005influential reference
• HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart.

  2005cited by this paper
• Protection "outside the box" (skeletal remote preconditioning) in rat model is triggered by free radical pathway.

  2005cited by this paper
• Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment.

  2005cited by this paper
• Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection.

  2005influential reference
• Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid-mediated stromal-cell-derived factor-1α treatment

  2005cited by this paper
• Bone marrow as a source of circulating CXCR4+ tissue‐committed stem cells

  2005cited by this paper
• N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia.

  2005cited by this paper
• Signaling factors in stem cell-mediated repair of infarcted myocardium.

  2005cited by this paper
• An Oxygen Transport Model for Human Bone Marrow Microcirculation

  2004cited by this paper
• Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

  2004cited by this paper
• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

  2004cited by this paper
• Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia.

  2004cited by this paper
• Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury

  2004cited by this paper
• Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression.

  2004cited by this paper
• A novel protective effect of erythropoietin in the infarcted heart.

  2003influential reference
• Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

  2003cited by this paper
• Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury

  2003influential reference
• Regulation of the Chemokine Receptor CXCR4 by Hypoxia

  2003influential reference
• Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression

  2003cited by this paper
• Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.

  2003cited by this paper
• G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

  2002cited by this paper
• Chronic and Intermittent Hypoxia Induce Different Degrees of Myocardial Tolerance to Hypoxia-Induced Dysfunction

  2002influential reference
• Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1*

  2001cited by this paper
• Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

  2001cited by this paper
• Physiological and Genomic Consequences of Intermittent Hypoxia Invited Review : Adaptive responses of skeletal muscle to intermittent hypoxia : the known and the unknown

  2001cited by this paper
• Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms.

  2001cited by this paper
• HIF-1: mediator of physiological and pathophysiological responses to hypoxia.

  2000influential reference
• Inactivation of erythropoietin leads to defects in cardiac morphogenesis.

  1999cited by this paper
• Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.

  1998cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996influential reference
• Human erythropoietin receptor: cloning, expression, and biologic characterization.

  1990cited by this paper
• Kinetics of hemopoietic stem cells in a hypoxic culture

  1988cited by this paper
• Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

  1986cited by this paper
• highlighted topics Physiological and Genomic Consequences of Intermittent Hypoxia Invited Review: Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms

  year unknowncited by this paper
• highlighted topics Physiological and Genomic Consequences of Intermittent Hypoxia Invited Review: Physiological and pathophysiological responses to intermittent hypoxia

  year unknowninfluential reference

• Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system

  2025cites this paper
• Relationship of passive hypothermia during transport with the incidence of early multiorgan compromise in newborns with perinatal asphyxia.

  2023cites this paper
• Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy

  2023cites this paper
• TRPV1 Hyperfunction Contributes to Renal Inflammation in Oxalate Nephropathy

  2021cites this paper
• Stem Cell Metabolism: Powering Cell-Based Therapeutics

  2020cites this paper
• Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.

  2020cites this paper
• Tumor Microenvironment: Signaling Pathways – Part A

  2020cites this paper
• Neovascularization by sustained delivery of G-CSF, EPO and VEGF using dextran/PLGA microspheres.

  2020cites this paper
• Hypoxic preconditioning — A nonpharmacological approach in COVID-19 prevention

  2020cites this paper
• The combination of G9a histone methyltransferase inhibitors with erythropoietin protects heart against damage from acute myocardial infarction.

  2020cites this paper
• Pleiotropic effects of Erythropoietin. Influence of Erythropoietin on processes of mesenchymal stem cells differentiation

  2019cites this paper
• Exposing immature hippocampal neurons to excitotoxins reveals distinct transcriptome and protein regulation with induction of common survival signaling pathways.

  2019cites this paper
• The direct effect of lipopolysaccharide on an isolated heart is different from the effect on cardiac myocytes in vitro

  2019cites this paper
• ENDOTHELIAL DYSFUNCTION UNDER INFLUENCE OF IONIZING RADIATION: PATHOGENETIC BASIS AND OPPORTUNITIES OF PHARMACOLOGICAL CORRECTION

  2018cites this paper
• Promising roles of erythropoietin and lymphotoxin alpha in critical illness: A pilot study in critically ill children

  2018cites this paper
• Erythropoietin, Stem Cell Factor, and Cancer Cell Migration.

  2017cites this paper
• 5 Cytoprotection and Preconditioning for Stem Cell Therapy

  2017cites this paper
• Interleukin-27 Protects Cardiomyocyte-Like H9c2 Cells against Metabolic Syndrome: Role of STAT3 Signaling

  2015cites this paper
• Characterization of reactive oxygen species in diaphragm

  2015cites this paper
• Interleukin-27, a novel cytokine induced by ischemia–reperfusion injury in rat hearts, mediates cardioprotective effects via the gp130/STAT3 pathway

  2015cites this paper
• Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial

  2015cites this paper
• Ischemic preconditioning for cell-based therapy and tissue engineering.

  2014cites this paper
• Early-life seizures in predisposing neuronal preconditioning: a critical review.

  2014cites this paper
• Preconditioned stem cells: a promising strategy for cell-based ischemic stroke therapy.

  2014cites this paper
• Hypoxic preconditioning protects rat hearts against ischemia–reperfusion injury via the arachidonate12-lipoxygenase/transient receptor potential vanilloid 1 pathway

  2014cites this paper
• Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment.

  2013cites this paper
• Long-Lasting Changes in DNA Methylation Following Short-Term Hypoxic Exposure in Primary Hippocampal Neuronal Cultures

  2013cites this paper
• HIV-1 gp120 induces autophagy in cardiomyocytes via the NMDA receptor.

  2013cites this paper
• Migration of Resident Cardiac Stem Cells in Myocardial Infarction

  2013cites this paper
• Epo and non-hematopoietic cells: what do we know?

  2013cites this paper
• Baicalein preconditioning protects cardiomyocytes from ischemia-reperfusion injury via mitochondrial oxidant signaling.

  2013cites this paper
• Hypothermic protection in traumatic brain injury.

  2013cites this paper
• Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation

  2013cites this paper
• Preconditioning Strategy in Stem Cell Transplantation Therapy

  2013cites this paper
• Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin

  2012cites this paper
• Equivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning

  2012cites this paper
• Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats

  2012influential citation
• Autologous peripheral blood-derived mononuclear cells induced by erythropoietin improve critical ischemic limbs.

  2012cites this paper
• Mitochondrial proteome design: From molecular identity to pathophysiological regulation

  2012cites this paper
• Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.

  2012cites this paper
• Stromal cell derived factor-1 (SDF-1) targeting reperfusion reduces myocardial infarction in isolated rat hearts.

  2012influential citation
• Influence of temperature on ischemic brain: basic and clinical principles.

  2012cites this paper
• Effects of myocardial postconditioning on the recruitment of endothelial progenitor cells.

  2012cites this paper
• Mechanisms for progenitor cell-mediated repair for ischemic heart injury.

  2012cites this paper
• Role of Induced Hypothermia in Thoracoabdominal Aortic Aneurysm Surgery

  2012cites this paper
• Ex vivo ischaemic and hypoxic preconditioning of stem cells

  2012cites this paper
• Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.

  2012cites this paper
• Protection of Bone Marrow-Derived CD45(superscript +)/CD34(superscript -)/lin(superscript -) Stromal Cells with Immunosuppressant Activity against Ischemia/Reperfusion Injury in Rats

  2011cites this paper
• Protection of bone marrow-derived CD45+/CD34-/lin- stromal cells with immunosuppressant activity against ischemia/reperfusion injury in rats.

  2011cites this paper
• Cardiac injury protection from mouse bone marrow stromal cells with in utero transplantation followed by secondary postnatal boost.

  2011cites this paper
• Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke

  2011cites this paper
• Early Erythropoietin Therapy Attenuates Remodeling and Preserves Function of Left Ventricle in Porcine Myocardial Infarction

  2011cites this paper
• Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies.

  2011cites this paper
• Effect of hyperbaric oxygen therapy on the intestinal ischemia reperfusion injury.

  2011cites this paper
• Ischemia / Reperfusion Effect of hyperbaric oxygen therapy on the intestinal ischemia reperfusion injury

  2011cites this paper
• Erythropoietin, erythropoiesis and beyond.

  2011cites this paper
• Cytoprotection and Preconditioning for Stem Cell Therapy

  2011cites this paper
• Endothelial progenitor cells in cardiovascular disease and hypoxia--potential implications to obstructive sleep apnea.

  2011cites this paper
• Etude des mécanismes cellulaires et moléculaires de l'inhibition de l'érythropoïèse par la cytokine pro-inflammatoire Tumor necrosis factor (TNF)-alpha

  2011cites this paper
• Novel Strategies for Neurovascular Longevity During Aging

  2010cites this paper
• Early exposure of cultured hippocampal neurons to excitatory amino acids protects from later excitotoxicity

  2010influential citation
• Erythropoietin Markedly Attenuates Brain Infarct Size and Improves Neurological Function in the Rat

  2010cites this paper
• Mechanosensitive transient receptor potential vanilloid type 1 channels contribute to vascular remodeling of rat fistula veins.

  2010cites this paper
• Oxidative stress: Biomarkers and novel therapeutic pathways

  2010cites this paper
• Induction of a hypometabolic state during critical illness - a new concept in the ICU?

  2010cites this paper
• Mechanisms of action, physiological effects, and complications of hypothermia

  2009cites this paper
• Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology

  2009cites this paper